Chemed (CHE) Cost of Revenue (2009 - 2026)

Chemed's Cost of Revenue history runs 18 years deep, the most recent figure standing at $441.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 2.61% year-over-year to $441.7 million; the TTM figure through Mar 2026 stood at $1.7 billion (up 5.9% YoY), while the FY2025 annual figure was $1.7 billion, up 8.23% from the prior year.
• Cost of Revenue was $441.7 million for Q1 2026 at Chemed, up from $414.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $441.7 million in Q1 2026 to a low of $336.6 million in Q1 2022.
• Historically, Cost of Revenue has averaged $385.9 million across 5 years, with a median of $385.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue fell 3.9% in 2022, then increased 13.26% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $349.6 million in 2022, then grew by 2.51% to $358.3 million in 2023, then climbed by 13.26% to $405.9 million in 2024, then advanced by 2.04% to $414.2 million in 2025, then rose by 6.66% to $441.7 million in 2026.
• The last three Cost of Revenue figures came in at $441.7 million (Q1 2026), $414.2 million (Q4 2025), and $428.0 million (Q3 2025), per Business Quant data.